Inside the Curavit and Lindus CRO deal
The decentralized trial hype has faded, but the direct-to-patient model has matured, and the teams running it now...
Categories
Connect with us on LinkedIn
Next-Generation Digital Study Infrastructure LinkedIn Live
The decentralized trial hype has faded, but the direct-to-patient model has matured, and the teams running it now...
The RWE Crossroad: the physician, the patient, or the machine?
Real-world evidence has more ways than ever to capture a patient's story: directly from patients, from medical records...
Castor Essentials: the fastest route to compliant medical device trials
Early-stage medical device, diagnostic, and IVD teams face a hard trade-off: legacy EDCs are overkill for a pilot...
Can AI actually help sites?
Most clinical sites still capture protocol visit data on paper, and most AI pitched at them falls apart...
Where AI is actually saving time in eCOA, and the work it still can’t touch
The process for localizing patient questionnaires and moving them onto screens has barely changed in twenty years, while...
AI in eCOA: What Works. What Breaks
AI is being applied to eCOA localization, but most teams are still figuring out where it genuinely helps...
PMCF requirements are raising hard questions about cost, device viability, and where AI fits in
Most PMCF programs weren't designed for EU MDR. They were built before Article 61(11) made ongoing clinical data...
The Temporal Conundrum: Bridging the Gap Between Manual UAT and AI Automation in eCOA
Manual eCOA UAT runs 12-16 weeks because time-dependent protocol logic must be tested across a study's full duration....
End the surgical data entry burden: AI-assisted, human-supervised, 80% faster
On May 6, 2026, Castor and SAGES are hosting a 30-minute session on ending the surgical data entry...
Leveraging the patient voice to reduce regulatory uncertainty during submission
Learn how PRO data closes evidence gaps in FDA and EMA submissions. Join outcomes expert Ari Gnanasakthy and...
Biotech AI strategy for clinical teams | LinkedIn Live
LinkedIn Live event tile featuring Derk Arts, CEO of Castor, and Solomon Babani, Founder and CEO of Symbiosis...
Practical ICH E6(R3) Oversight for Your Centralized Monitoring Strategy – On Demand
Adopting ICH E6(R3) requires a shift from site-based monitoring to centralized oversight. Watch this on-demand Product Spotlight to...
Product Spotlight The Self-Driving Study with Castor Catalyst – On Demand
Join Castor CEO Derk Arts to explore Castor Catalyst, the agentic AI platform built with Google Cloud AI....
Castor Product Spotlight: New On-site ePRO
Watch this on-demand Product Spotlight to see Castor’s On-site ePRO in action. Our experts show how on-site capture...
Broken at Baseline: Why eCOA Fails in the Real World (and Why We Don’t Talk About It)
Why are baseline PROs still going uncaptured in 2025? Join Ari Gnanasakthy, Katja Rudell & Derk Arts to...
From Hype to Health: How Sword Built Evidence That Scales
How Sword Health used long-term clinical validation to scale, prove outcomes, and build real credibility in digital MSK...
Product Spotlight: What’s New in 2025?
Discover how Castor's latest product updates in 2025 can improve your day-to-day operations, and the participant experience.
Connect with us on LinkedIn
